Immunotherapy | Tumor

CURE’s immunotherapy page features the latest cancer news and updates on immunotherapy Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in immunotherapy.

The 'Promise' of Precision Medicine: Making Incurable Cancers Into Chronic Diseases

October 1st 2021, 7:00pm


One oncologist highlighted the knowledge base of the immunotherapy and targeted therapy and how they interact with cancer cells.

Further Evaluating Biomarkers May Help to Better Interpret Which Patients Are Eligible For Immunotherapy

September 29th 2021, 7:00pm


Getting rid of the "blanket statement" and looking deeper into genetics may allow patients with cancer who are older than 60 years to become eligible for immunotherapy, highlighting the importance of further research on the topic.

The Impact of Immunotherapy

June 25th 2021, 6:00pm


Thanks to ongoing research and clinical trials, it seems that there are always new immunotherapies emerging.

Bispecific Antibodies Wage a Two-Pronged Attack on Tumors

June 16th 2021, 3:00pm


BiTE therapy could lead to better ways to target the immune system, while minimizing the chance of resistance.

Intralesional Therapies Help Bridge the Gap Between Improved Results and Less Toxicity

June 15th 2021, 3:00pm


First immunotherapy, intralesional therapy, is making a comeback and producing durable remissions for a subgroup of patients with cancer.

Tecentriq Significantly Improves Survival Outcome in Patients with Early-Stage Non-Small Cell Lung Cancer

May 21st 2021, 1:00pm


The data, according to an expert, show that treatment with Tecentriq could delay disease progression to an advanced stage, as well as the need for more aggressive therapy.

Immunotherapy Could 'Provide A Whole New Realm' For Patients with Myeloma

May 14th 2021, 6:00pm


New advances in research around immunotherapies for patients with myeloma are on the horizon, according to an expert from the HealthTree Foundation & Myeloma Crowd.

Our Microbiome: A Reflection of Ourselves?

May 9th 2021, 3:00pm


Sophisticated analyses can predict which gut microbiome profile may lead to better outcomes to immunotherapy for patients with advanced melanoma.

Follow Your Gut: Advances in Understanding Microbiomes Are Transforming Cancer Care

April 28th 2021, 6:00pm


The gut microbiome plays an important role in how patients may respond to cancer treatments, and researchers are learning more about ways to alter it to benefit treatment outcomes.

Targeting a Specific Genetic Mutation May Change Treatment Landscape for Non-Small Cell Lung Cancer

April 21st 2021, 9:00pm


Patients with non-small cell lung cancer and a KRAS G12C genetic mutation may benefit from treatment with an inhibitor targeting that mutation, although more research is needed to learn why more patients are not responding to the drug.